CASI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 21.24%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

CASI Pharmaceuticals Insider Trading History Chart

CASI Pharmaceuticals Share Price & Price History

^$2.51

▲ +0.08 (3.29%)

As of 04/23/2024 01:00 AM ET

Days: 30 | 90 | 365

Biden replacement revealed?

From Paradigm Press | Ad

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

See his shocking evidence in this new report

CASI Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/8/2022	James Huang	Director	Buy	33,300	$4.28	$142,524.00	371,517
9/6/2022	James Huang	Director	Buy	19,162	$3.89	$74,540.18	335,106
8/26/2022	James Huang	Director	Buy	39,527	$3.75	$148,226.25	278,748
8/24/2022	James Huang	Director	Buy	5,000	$3.75	$18,750.00	239,221
8/22/2022	James Huang	Director	Buy	23,105	$3.46	$79,943.30	194,221
8/19/2022	James Huang	Director	Buy	171,116	$3.27	$559,549.32	171,116
11/17/2021	Wei-Wu He	CEO	Buy	200,000	$0.99	$198,000.00

How to camouflage a factory of 53,000 workers

From Stansberry Research | Ad

"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."

Get the full story here.

SEC Filings (Institutional Ownership Changes) for CASI Pharmaceuticals (NASDAQ:CASI)

22.23% of CASI Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

CASI Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/11/2023	Wellington Shields Capital Management LLC	180,143	$0.42M	0.1%	N/A	1.352%
5/11/2023	Wellington Shields & Co. LLC	139,315	$0.32M	0.1%	N/A	1.046%
11/4/2022	Prudential Financial Inc.	11,000	$29K	0.0%	N/A	0.081%
9/16/2022	Federated Hermes Inc.	1,015,000	$2.90M	0.0%	-90.0%	7.460%
8/15/2022	Wellington Shields Capital Management LLC	213,250	$0.61M	0.1%	-90.0%	1.567%
8/12/2022	Ikarian Capital LLC	132,014	$0.38M	0.1%	-90.0%	0.970%
8/12/2022	Wellington Shields & Co. LLC	145,317	$0.42M	0.1%	-90.0%	1.068%
7/27/2022	Bailard Inc.	31,530	$90K	0.0%	+25.6%	0.232%
5/12/2022	Wellington Shields Capital Management LLC	2,132,547	$1.73M	0.2%	-2.6%	1.561%
5/9/2022	Wellington Shields & Co. LLC	1,453,190	$1.18M	0.4%	+27.3%	1.064%
2/16/2022	Wellington Shields & Co. LLC	1,141,190	$0.91M	0.2%	-37.7%	0.816%
2/15/2022	Wellington Shields Capital Management LLC	2,188,547	$1.75M	0.2%	-3.1%	1.566%
11/15/2021	Marshall Wace LLP	952,037	$1.13M	0.0%	+325.6%	0.681%
11/12/2021	Renaissance Technologies LLC	1,618,155	$1.93M	0.0%	+4.6%	1.158%
11/12/2021	Geode Capital Management LLC	944,729	$1.12M	0.0%	+34.2%	0.676%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	60,904	$72K	0.0%	N/A	0.044%
11/10/2021	Goldman Sachs Group Inc.	199,986	$0.24M	0.0%	+32.3%	0.143%
11/9/2021	BlackRock Inc.	1,165,942	$1.39M	0.0%	-1.3%	0.834%
8/26/2021	Y Intercept Hong Kong Ltd	16,246	$25K	0.0%	N/A	0.012%
8/25/2021	Marshall Wace LLP	223,709	$0.35M	0.0%	N/A	0.160%
8/17/2021	Millennium Management LLC	1,112,208	$1.72M	0.0%	+1,211.7%	0.796%
8/17/2021	Price T Rowe Associates Inc. MD	105,200	$0.16M	0.0%	-32.3%	0.075%
8/17/2021	Prudential Financial Inc.	16,600	$26K	0.0%	N/A	0.012%
8/17/2021	Boothbay Fund Management LLC	185,988	$0.29M	0.0%	+14.8%	0.133%
8/16/2021	Squarepoint Ops LLC	22,698	$35K	0.0%	+107.4%	0.016%
8/16/2021	LMR Partners LLP	30,360	$47K	0.0%	N/A	0.022%
8/16/2021	Schonfeld Strategic Advisors LLC	20,600	$32K	0.0%	N/A	0.015%
8/16/2021	Charles Schwab Investment Management Inc.	405,290	$0.63M	0.0%	-20.0%	0.290%
8/16/2021	State Street Corp	194,842	$0.30M	0.0%	-81.3%	0.139%
8/16/2021	Tibra Equities Europe Ltd	216,300	$0.34M	0.1%	N/A	0.155%
8/16/2021	Goldman Sachs Group Inc.	151,183	$0.23M	0.0%	+143.6%	0.108%
8/16/2021	Marshall Wace LLP	223,709	$0.35M	0.0%	N/A	0.160%
8/16/2021	Wellington Shields Capital Management LLC	2,258,264	$3.50M	0.4%	+1.2%	1.615%
8/13/2021	Renaissance Technologies LLC	1,546,306	$2.40M	0.0%	+504.7%	1.106%
8/13/2021	Northern Trust Corp	243,200	$0.38M	0.0%	-70.4%	0.174%
8/13/2021	Geode Capital Management LLC	703,888	$1.09M	0.0%	-35.6%	0.504%
8/13/2021	Vanguard Group Inc.	3,904,627	$6.05M	0.0%	-7.6%	2.793%
8/13/2021	Bailard Inc.	40,400	$63K	0.0%	N/A	0.029%
8/12/2021	Dimensional Fund Advisors LP	274,344	$0.43M	0.0%	+4.6%	0.196%
8/12/2021	JPMorgan Chase & Co.	191,523	$0.30M	0.0%	+8.7%	0.137%
8/12/2021	Ergoteles LLC	300,400	$0.47M	0.0%	N/A	0.215%
8/11/2021	Bank of New York Mellon Corp	36,436	$56K	0.0%	-80.6%	0.026%
8/11/2021	BlackRock Inc.	1,181,599	$1.83M	0.0%	-70.5%	0.845%
8/5/2021	GSA Capital Partners LLP	78,572	$0.12M	0.0%	+377.9%	0.056%
8/1/2021	Sterneck Capital Management LLC	40,000	$47K	0.0%	N/A	0.029%
7/31/2021	Mosaic Family Wealth LLC	17,500	$27K	0.0%	N/A	0.013%
5/19/2021	Virtu Financial LLC	66,106	$0.16M	0.0%	+431.0%	0.047%
5/19/2021	Squarepoint Ops LLC	10,943	$26K	0.0%	N/A	0.008%
5/18/2021	Millennium Management LLC	84,791	$0.20M	0.0%	-34.3%	0.061%
5/18/2021	D. E. Shaw & Co. Inc.	22,596	$54K	0.0%	N/A	0.016%
5/18/2021	Cubist Systematic Strategies LLC	21,100	$51K	0.0%	+51.5%	0.015%
5/17/2021	Aristides Capital LLC	63,250	$0.15M	0.1%	N/A	0.045%
5/17/2021	Price T Rowe Associates Inc. MD	155,288	$0.37M	0.0%	+37.5%	0.111%
5/17/2021	Nuveen Asset Management LLC	283,079	$0.68M	0.0%	+20.4%	0.202%
5/17/2021	Goldman Sachs Group Inc.	62,052	$0.15M	0.0%	+109.8%	0.044%
5/14/2021	Ghost Tree Capital LLC	650,000	$1.56M	0.4%	N/A	0.465%
5/14/2021	Dimensional Fund Advisors LP	262,374	$0.63M	0.0%	+766.2%	0.188%
5/14/2021	Vident Investment Advisory LLC	54,829	$0.13M	0.0%	-39.3%	0.039%
5/14/2021	XTX Topco Ltd	14,215	$34K	0.0%	N/A	0.010%
5/13/2021	Barclays PLC	55,269	$0.13M	0.0%	+159.0%	0.040%
5/13/2021	Renaissance Technologies LLC	255,700	$0.61M	0.0%	+261.1%	0.183%
5/13/2021	Federated Hermes Inc.	10,150,000	$24.36M	0.0%	+45.0%	7.261%
5/12/2021	Northern Trust Corp	820,622	$1.97M	0.0%	-12.7%	0.587%
5/12/2021	Geode Capital Management LLC	1,092,677	$2.62M	0.0%	+14.1%	0.782%
5/12/2021	Wellington Shields & Co. LLC	1,832,769	$4.40M	1.6%	+1.1%	1.311%
5/12/2021	Wellington Shields Capital Management LLC	2,231,765	$5.36M	0.5%	+7.7%	1.596%
5/12/2021	1492 Capital Management LLC	79,743	$0.19M	0.1%	N/A	0.057%
5/12/2021	JPMorgan Chase & Co.	176,221	$0.42M	0.0%	-4.2%	0.126%
5/12/2021	Panagora Asset Management Inc.	125,747	$0.30M	0.0%	N/A	0.090%
5/10/2021	GSA Capital Partners LLP	16,442	$39K	0.0%	-68.5%	0.012%
5/7/2021	BlackRock Inc.	4,006,960	$9.62M	0.0%	+4.6%	2.866%
5/6/2021	Quantitative Systematic Strategies LLC	21,561	$52K	0.0%	N/A	0.015%
4/30/2021	Creative Planning	40,009	$96K	0.0%	N/A	0.029%
4/12/2021	FNY Investment Advisers LLC	49,400	$0.12M	0.0%	N/A	0.035%
3/26/2021	Susquehanna International Group LLP	13,290	$39K	0.0%	-50.2%	0.011%
3/8/2021	Dimensional Fund Advisors LP	30,290	$89K	0.0%	N/A	0.024%
2/25/2021	Dimensional Fund Advisors LP	30,290	$89K	0.0%	N/A	0.024%
2/24/2021	Virtu Financial LLC	12,450	$37K	0.0%	-67.7%	0.010%
2/23/2021	Principal Financial Group Inc.	14,414	$43K	0.0%	N/A	0.012%
2/19/2021	JPMorgan Chase & Co.	183,922	$0.54M	0.0%	+281.1%	0.148%
2/16/2021	Price T Rowe Associates Inc. MD	112,917	$0.33M	0.0%	+53.7%	0.091%
2/16/2021	Charles Schwab Investment Management Inc.	480,106	$1.42M	0.0%	+1.7%	0.387%
2/12/2021	Federated Hermes Inc.	7,000,000	$20.65M	0.0%	+1.4%	5.648%
2/12/2021	The Manufacturers Life Insurance Company	45,064	$0.13M	0.0%	+121.5%	0.036%
2/12/2021	Ikarian Capital LLC	1,268,154	$3.74M	0.2%	-17.6%	1.023%
2/12/2021	Credit Suisse AG	19,406	$57K	0.0%	N/A	0.016%
2/11/2021	Northern Trust Corp	940,103	$2.77M	0.0%	+3.8%	0.758%
2/11/2021	Barclays PLC	21,341	$63K	0.0%	-28.3%	0.017%
2/11/2021	Citigroup Inc.	11,781	$35K	0.0%	+271.1%	0.010%
2/10/2021	Rhumbline Advisers	73,286	$0.22M	0.0%	+11.5%	0.059%
2/10/2021	Renaissance Technologies LLC	70,813	$0.21M	0.0%	-88.2%	0.057%
2/9/2021	Wells Fargo & Company MN	169,768	$0.50M	0.0%	+4.2%	0.137%
2/9/2021	Bank of New York Mellon Corp	187,679	$0.55M	0.0%	+6.8%	0.151%
2/9/2021	Wellington Shields Capital Management LLC	2,071,765	$6.11M	0.8%	+45.4%	1.672%
2/9/2021	Wellington Shields & Co. LLC	1,812,769	$5.35M	1.9%	+22.5%	1.463%
2/9/2021	ProShare Advisors LLC	14,651	$43K	0.0%	N/A	0.012%
2/5/2021	BlackRock Inc.	3,830,466	$11.30M	0.0%	+9.1%	3.090%
2/4/2021	GSA Capital Partners LLP	52,146	$0.15M	0.0%	+157.4%	0.042%
2/4/2021	State of Wisconsin Investment Board	91,900	$0.27M	0.0%	N/A	0.074%
12/11/2020	Virtu Financial LLC	38,496	$59K	0.0%	N/A	0.031%

Data available starting January 2016

CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People's Republic of China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's other hematology/oncology assets in pipeline include CNCT 19, an autologous CD19 CAR-T investigative product; BI-1206, novel anti-Fc?RIIB antibody, for the treatment of solid tumors and relapsed/refractory non-hodgkin lymphoma; CB-5339, a novel VCP/p97 inhibitor that focuses on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis, DNA damage response, and other cellular stress pathways for therapeutic use in the treatment of patients with various malignancies; and CID-103, a human IgG1 anti-CD38 monoclonal antibody. The company has licensing agreements with Juventas Biotechnology (Tianjin) Co., Ltd.; BioInvent International AB; Black Belt Therapeutics Limited; Cleave Therapeutics, Inc.; and Acrotech Biopharma L.L.C. to develop and commercialize its commercial product EVOMELA. It also has distribution agreements with China Resources Pharmaceutical Commercial Group International Trading Co., Ltd; Pharmathen Global BV; and Riemser Pharma GmbH. CASI Pharmaceuticals, Inc. was incorporated in 1991 and is based in Beijing, the People's Republic of China.

Today's Range

Now: $2.51

$2.36

$2.51

50 Day Range

MA: $3.98

$2.24

$6.09

52 Week Range

Now: $2.51

$1.85

$8.48

Volume

12,047 shs

Average Volume

171,932 shs

Market Capitalization

$33.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of CASI Pharmaceuticals?: CASI Pharmaceuticals' top insider investors include:
James Huang (Director)
Learn More about top insider investors at CASI Pharmaceuticals.